• Mashup Score: 0

    AuthorsDaniel D. BuchananUniversity of Melbourne, Parkville, VIC, AustraliaDaniel D. Buchanan, Khalid Mahmood, Peter Georgeson, Romy Walker, Kristy Robledo, Michelle M. Cummins, Amanda B. Spurdle, Deborah S Smith, Eric Joo, Mark Clendenning, Julia Como, Susan Preston, Sonia Yip, John Andrews, Peey Sei Kok, Yeh Chen Lee, Martin R. Stockler, Linda R. Mileshkin, Yoland Catherine…

    Tweet Tweets with this article
  • Mashup Score: 3

    Our specialised CUP clinic facilitated diagnostic work-up among patients with suspected malignancy and provided access to genomic testing and clinical trials for patients with a CUP diagnosis, all of which are important to improve outcomes in this patient population.

    Tweet Tweets with this article
    • Very pleased to see this out now! Six-year experience of Australia's first dedicated cancer of unknown primary clinic https://t.co/QM9Gb9gwNZ Found we can often make a more specific diagnosis that CUP and also use genomic profiling to improve outcomes 4 patients

  • Mashup Score: 0

    WomenCan’s Larapinta trek in the Northern Territory has become a popular activity on the calendar, attracting ANZGOG members; WomenCan supporters, and people with a lived experience of gynaecological cancer all pulling on their hiking boots, hitting the trail, and raising funds for ANZGOG’s research programs. ANZGOG member Professor Linda Mileshkin lives a very busy life. Linda is the Director of…

    Tweet Tweets with this article
  • Mashup Score: 0
    Layout - 2 year(s) ago

    I’m taking on a huge challenge to support an incredible cause. Please sponsor me by clicking the link. Thanks so much!

    Tweet Tweets with this article
    • My husband & I are doing this fundraising walk for gynae cancer research @ANZGOG in Larapinta in Aug. Trying to do lots of training! Much appreciated if you might donate to our group who does lots of great #cancerresearch https://t.co/JQ0qP4SaMD

  • Mashup Score: 0

    Why ovarian cancer treatment stops working A world-first, international study led by researchers at Peter MacCallum Cancer Centre has identified why some ovarian cancer patients become resistant to treatment, paving the way for new techniques to treat the deadly cancer. A world-fi

    Tweet Tweets with this article
  • Mashup Score: 0

    Knowledge of contemporary patterns of cancer-of-unknown-primary-origin (CUP) diagnostic work-up, treatment, and outcomes in routine healthcare is limited. Thus, we examined data from elderly patients diagnosed with CUP in real-world US clinical practice. From the Surveillance, Epidemiology, and End Results–Medicare-linked database, we included patients ≥ 66 years old with CUP diagnosed between 1…

    Tweet Tweets with this article
    • Latest article highlighting that many US patients >65 with possible metastatic cancer (registry labelled as CUP) don't even given get a biopsy to make a diagnosis. Some may be very frail/ too unwell 4 treatment, but I suspect this is not the case for all https://t.co/qjSjSsaCRz

  • Mashup Score: 0

    Molecular profiling of tumours to identify targetable alterations is rapidly developing and is now part of clinical practice for a range of cancers. Genomic testing needs a co-ordinated approach to specimen collection, testing and reporting, and it’s important to be aware of the types of genomic variants reported by the laboratory and the technology used […]

    Tweet Tweets with this article
    • Great to talk to @ProfDMThomas and Stephen Fox from @PeterMacCC on this podcast.Precision medicine and companion diagnostics for oncologists – testing, reporting and actionability: https://t.co/AvPIDHTR6H